Novadip
Regenerative Medicine
$11.2MTotal raised
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 21, 2026Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
- Founded
- 2013
- Official records
- Wikidata Q30269210
- Website
- novadip.com
These are the key facts about Novadip on Alion as of Nov 21, 2026. It was founded in 2013. The latest round is Venture - Series Unknown of $11.2M, announced in 2026.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Funding
Full ledger, 1 record →Novadip has $11.2M paid in by investors, lenders and donors.
$11.2MPaid in
Money innewest first
$11.2MPaid
Money by yearUSD, rounds and grants
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Ownership
All holders and entities →Sources name U.S among the owners or investors of Novadip.
Named investors, no share stated1
U.S
Holders and shares as each register or filing states them.
Risk
Full record →Novadip in public registers.
No match
None
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Milestones
Oct 2
Raised a round Venture round $11.2M · led by U.S · Pulse 2.0
2013
Founded
Each milestone is dated by its source: registers, filings, the press
Newsroom
Oct 22026
News · Pulse 2.0
Novadip Biosciences has raised €10.4 million ($11.98 million) in convertible financing to advance its lead regenerative medicine program NVD003 through pivotal Phase 3 developmen…
Sources: the outlets named on each headline, each story once
